The Pharmacy Times® Flu Resource Center is a comprehensive resource for clinical news and expert insights on the treatment of influenza, a contagious viral infection that can cause mild to severe symptoms and life-threatening complications.
August 18th 2025
Researchers unveil a promising drug combination, arainosine and theobromine, that effectively targets influenza A M2 channels, outperforming existing treatments.
IDSA Updates Guidelines on Flu Diagnosis and Response
December 28th 2018The guidelines recommend using molecular tests that deliver results in 15-60 minutes instead of rapid-influenza diagnostic tests (RIDTs), which produce quick results but can be falsely negative in at least 30% of outpatients with influenza.
Read More
First New Antiviral for Influenza in 2 Decades Approved by FDA
October 24th 2018Officials with the FDA have approved baloxavir marboxil (Xofluza, Shionogi) for the treatment of acute uncomplicated influenza in patients aged 12 years and older who have been symptomatic for no more than 48 hours.
Read More
Independent Pharmacists: Separate Yourself From the Competition
October 7th 2018Offering immunizations (and making sure to carefully assess immunizations are up to date), medication therapy management (MTM), medication synchrnonization, and point of care testing are all ways, Kneeland explained, that pharmacists can carve out a niche for themselves.
Read More
Edward Jenner created the first vaccine to protect against smallpox in the 1790s.1 Since then, the pathway to effective and safe vaccines has not been direct or easy, yet millions of lives have been saved, proving that vaccines, in general, are powerful medical interventions.1
Read More
Investigational Antiviral Flu Drug Achieves Efficacy Goal in Phase 3 Trial
July 18th 2018The phase 3 CAPSTONE-2 study of the safety and efficacy of baloxavir marboxil in patients at high risk of complications due to influenza (flu) has met the primary objective of efficacy of a single dose of baloxavir marboxil compared to placebo.
Read More